Special Education Laws

Dec 10, 2016 by in ONCOLOGY Comments Off on Special Education Laws

© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_23 23. Special Education Laws Michael E. Jewell1   (1) Law Offices of Michael…

read more

Lifestyle Factors and Health Risk Behaviors

Dec 10, 2016 by in ONCOLOGY Comments Off on Lifestyle Factors and Health Risk Behaviors

© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_21 21. Lifestyle Factors and Health Risk Behaviors Vida L. Tyc1   and James L. Klosky2  …

read more

Cultural and Linguistic Issues in the Assessment and Treatment of Pediatric Cancer Survivors

Dec 10, 2016 by in ONCOLOGY Comments Off on Cultural and Linguistic Issues in the Assessment and Treatment of Pediatric Cancer Survivors

© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_19 19. Cultural and Linguistic Issues in the Assessment and Treatment…

read more

Resiliency in Childhood Cancer Survivors: A Clinician’s Perspective

Dec 10, 2016 by in ONCOLOGY Comments Off on Resiliency in Childhood Cancer Survivors: A Clinician’s Perspective

© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_18 18. Resiliency in Childhood Cancer Survivors: A Clinician’s Perspective Frances Wollman Baumgarten1  …

read more

Second Malignant Neoplasms

Dec 10, 2016 by in ONCOLOGY Comments Off on Second Malignant Neoplasms

Study GWAS vs. candidate gene Study design Replication Sample size Results Therapy-related leukemia-associated with exposure to alkylating agents and topoisomerase II inhibitors Genome-wide association studies Knight et al. 2009 [90]…

read more

Long-Term Follow-Up Roadmaps by Disease and Treatment

Dec 10, 2016 by in ONCOLOGY Comments Off on Long-Term Follow-Up Roadmaps by Disease and Treatment

Chemotherapy Dose Late effect Baseline screening Anthracycline ≥300 mg/m2 or Cardiomyopathy valvular, pericardial damage, coronary artery disease EKG, ECHO (Doxorubicin >200 mg/m2 + Daunorubicin Chest XRT ≥30 Gy Epirubicin HD…

read more

Eye, Ear and Oral Health

Dec 10, 2016 by in ONCOLOGY Comments Off on Eye, Ear and Oral Health

Question Response Did the patient have any of the following tumor types: neuroblastoma, brain tumor, germ cell tumor, osteosarcoma, hepatoblastoma? □ Yes □ No Did the patient receive cisplatin chemotherapy?…

read more
Get Clinical Tree app for offline access